It is not uncommon for a stock to have a lower trading volume the day before earnings are announced. In addition, the lack of any news from the company other than the general announcement associated with the FDA and its drug approval has dampened interest in the stock. Essentially nobody knows what is going on. Any word from the company will move this stock.